Nema internetske veze — prikazuje se spremljena verzija stranice.

60 Degrees Pharma…

USUSD
← Na Filtar Dionica

60 Degrees Pharmaceuticals, Inc. (US:SXTP) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 1. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O Tvrtki

Web-Stranica
60degreespharma.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
WASHINGTON, United States
Glavni Direktor
Geoffrey Stuart Dow
Zaposlenici
3
Dionice u Optjecaju
3.52 mil. na dan 2026-08-14
1 Godina: −14.3% · 3 godine: −52.6% (bez podjela dionica)
DatumDionicePromjena
14.08.20263.52 mil.+32.3%izdavanje (razvodnjavanje)
15.05.20262.66 mil.+0.9%izdavanje (razvodnjavanje)
30.03.20262.64 mil.−37.7%otkup
13.11.20254.23 mil.+3.1%izdavanje (razvodnjavanje)
13.08.20254.1 mil.+178.7%izdavanje (razvodnjavanje)
15.05.20251.47 mil.—nema značajnih promjena
27.03.20251.47 mil.obrnuta podjela 1:1.5
14.11.20242.3 mil.+29.9%izdavanje (razvodnjavanje)
14.08.20241.77 mil.−85.4%otkup
15.05.202412.14 mil.+4.9%izdavanje (razvodnjavanje)
01.04.202411.57 mil.podjela 2:1
20.11.20235.8 mil.—nema značajnih promjena
25.08.20235.8 mil.
Broj dionica prema izvješćima tvrtke. Podjela dionica prepoznaje se po skoku broja za cijeli broj puta.
Slobodno Prenosive Dionice
2.44 mil.
Tržišna Kapitalizacija
3.4 mil. USD
Insajderi
19.39%
Institucionalni Ulagači
17.11%
Djelatnost (SIC)
Pharmaceutical Preparations
P/E
gubitak
FCF
−8.89 mil. USD
Dug
150 tis. USD
neto novac
Zarada i FCF — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
Opis

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksSXTPUSD0.9 -1.70%obične dionice

Cijena za 3 Mjeseca

US:SXTP · USD
dan rasta dan padaPrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
Kathmere Capital Managem…7.54%265 1002026-06-30
MILLER TYRONE (Chief Fin…≈0.75%26 3702025-01-17
DOW GEOFFREY S (Chief Ex…≈0.69%24 1312026-06-12
Citadel Advisors Llc0.64%22 3622026-06-30
Xtx Topco Ltd0.5%17 6392026-06-30
XU CHERYL (Director)≈0.45%15 8162025-06-03
Kovack Advisors, Inc.0.43%15 0002026-06-30
Geode Capital Management…0.41%14 5512026-06-30
Fidelity Concord Street…0.41%14 3802026-07-31
UBS Group AG0.39%13 5922026-06-30
LANDON KRISTEN (Chief Op…≈0.13%4 5402025-01-17
Barclays Plc0.03%1 0522026-06-30
Osaic Holdings Inc.0%252026-06-30